A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Rugby fans told to expect queues of up to 2 hours to get home as thousands pour into the city for Wales' first Six Nations home game.
Green keeper Gareth Pugh died after he fell into a lake while collecting golf balls.
The Newsweek Quiz - where we will be testing your knowledge from the last seven days of news here in Wales.